New app-based program aims to boost sleep apnea treatment success

NCT ID NCT07494292

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 4-month personalized digital program (PASS) to help people with obstructive sleep apnea start and continue using positive airway pressure (PAP) therapy. Sixty overweight, inactive adults newly diagnosed with sleep apnea will be randomly assigned to either the PASS program or a general hygiene program. The PASS includes motivational interviewing, a digital platform for tracking and education, and chat-based support. Researchers will measure how many participants start PAP therapy and how often they use it, along with changes in sleep, activity, and diet.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Personalized and Adaptive Sleep Support (PASS) program

What this could lead to

If it works, this could help more people with sleep apnea successfully use their breathing machines, improving sleep and health.

What could go wrong

This is a small pilot study with only 60 participants, so results may not apply to everyone. The program is behavioral, so its success depends on individual motivation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA (OSA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••